GoodRx (GDRX): Scott Wagner Joins Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Scott Wagner Joins GoodRx Board of Directors
January 22, 2025 5:00 PM ESTFormer GoodRx Interim CEO brings a deep understanding of the GoodRx business and extensive leadership experience to his role as Co-Chair of the Board
SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx or the Company), the leading prescription savings platform in the U.S., today announced that Scott Wagner has joined its Board of Directors, effective January 21, 2025. Mr. Wagner, who recently led GoodRx as its Interim Chief Executive Officer from April 2023 to January 2025, has been appointed as Co-Chair of the Board and will serve... More
